Clinical trial · Observational
Association Between Multiple Coagulation-related Factors and Lymph Node Metastasis in Patients With Gastric Cancer: A Retrospective Cohort Study
NCT05592925CI-TRIAL-00061676MAunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
We initially selected a total of 1128 patients with primary gastric cancer who presented at Shandong Provincial Hospital between January 2018 and October 2022, and retrospectively collected their clinical and pathological data. And retrospectively analyzed preoperative baseline characteristics, preoperative laboratory tests, and postoperative pathological results for these patients
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer Stage | — | UNRESOLVED | — |
| Lymph Node Metastasis | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| coagulation-related factors | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- N0
- description
- gastric cancer patients with no lymph node metastasis
- interventionNames
- Diagnostic Test: coagulation-related factors
- label
- N+
- description
- gastric cancer patients with lymph node metastasis, including patients with N1, N2 and N3 stage cancer
- interventionNames
- Diagnostic Test: coagulation-related factors
Primary outcomes (6)
- measure
- Preoperative coagulation-related factors (MA values) of patients
- timeFrame
- Three years
- description
- MA values(mm). Measure the data of preoperative MA values in 516 gastric cancer patients to see wether this indicator correlated with tumor stage in patients with gastric cancer.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: 1. patients with primary gastric malignant tumors, 2. patients who underwent radical resection of gastric cancer, 3. patients with a postoperative pathology of adenocarcinoma or signet ring cell carcinoma according to the WTO pathological classification, Exclusion Criteria: 1. patients who have distant metastases, such as liver or lung metastases, were found on preoperative ultrasound and computed tomography (CT) examinations, 2. patients who have received preoperative neoadjuvant chemotherapy, 3. patients who take anticoagulant drugs (such as aspirin) prior to surgery, 4. patients who had any previous coagulation disorder.
References
Publications (0)
Data not yet available
No reference posted for this study.